20 results on '"Targum, Shari"'
Search Results
2. Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de Pointes
3. Drug Approval Process for Acute Heart Failure Syndrome in the United States
4. Troponin measurements during drug development—considerations for monitoring and management of potential cardiotoxicity: An educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration
5. Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development
6. Electrocardiographic assessment for therapeutic proteins—scientific discussion
7. Assessing proarrhythmic potential of drugs when optimal studies are infeasible
8. Is Randomization to Placebo Safe? Risk in Placebo-Controlled Angina Trials: Angina Risk Meta-Analysis
9. DUCHENNE MUSCULAR DYSTROPHY: DRUG DEVELOPMENT AND REGULATORY CONSIDERATIONS
10. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
11. Quantitative Understanding of QTc Prolongation and Gender as Risk Factors for Torsade de Pointes
12. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials
13. Contemporary Cardiac Issues in Duchenne Muscular Dystrophy
14. IMPROVING OUR UNDERSTANDING OF THE RELATIONSHIP BETWEEN QT PROLONGATION AND RISK OF TORSADE DE POINTES USING A QUANTITATIVE MODELING APPROACH
15. Bleeding Academic Research Consortium Consensus Report
16. Is Randomization to Placebo Safe? Risk in Placebo-Controlled Angina Trials: Angina Risk Meta-Analysis
17. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
18. Acute Heart Failure Syndromes
19. A clinical trial evaluating the 24‐hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension
20. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.